DIFFERENTIAL EXPRESSION OF TRANSFORMING GROWTH-FACTOR-ALPHA AND INSULIN-LIKE GROWTH-FACTOR-II IN CHRONIC ACTIVE HEPATITIS-B, CIRRHOSIS AND HEPATOCELLULAR-CARCINOMA
Bc. Park et al., DIFFERENTIAL EXPRESSION OF TRANSFORMING GROWTH-FACTOR-ALPHA AND INSULIN-LIKE GROWTH-FACTOR-II IN CHRONIC ACTIVE HEPATITIS-B, CIRRHOSIS AND HEPATOCELLULAR-CARCINOMA, Journal of hepatology, 22(3), 1995, pp. 286-294
In the present study we investigated the expression of transforming gr
owth factor alpha and insulin-like growth factor II to explain the rol
e of these growth factors in the development of hepatocellular carcino
ma from chronic active hepatitis B and cirrhosis, The expression of tr
ansforming growth factor alpha and insulin-like growth factor II was t
ested in 38 tissue samples from patients with chronic active hepatitis
B, 32 cirrhosis and 31 hepatocellular carcinoma, by immunohistochemic
al staining using monoclonal anti-transforming growth factor alpha and
anti-insulin-like growth factor II, All patients were seropositive fo
r HBsAg. Transforming growth factor alpha was expressed in 26 (68.4%)
of 38 chronic active hepatitis B, 18 (56.3%) of 32 cirrhosis and 16 (5
1.6%) of 31 hepatocellular carcinoma tissue samples, Transforming grow
th factor alpha was found in the periportal hepatocytes of chronic act
ive hepatitis B and in regenerating hepatocytes of cirrhotic nodules,
In hepatocellular carcinoma tissues, transforming growth factor alpha-
containing tumor cells were evenly distributed within the tumor tissue
s but focal distribution limited to a part of tumor tissues was also o
bserved, The expression of insulin-like growth factor II was observed
in 30 (93.8%) of 32 cirrhosis and all the 31 hepatocellular carcinoma
tissue samples tested, but not in chronic active hepatitis B samples,
Insulin-like growth factor Il was expressed in most hepatocytes of reg
enerating nodules and in tumorous as well as non-tumorous hepatocytes
of hepatocellular carcinoma tissues, The current study indicates that,
although enhanced expression of transforming growth factor alpha and
insulin-like growth factor II in chronic liver diseases may function i
n concert in multiple steps of hepatocarcinogenesis, insulinlike growt
h factor II may play a more predominant role than transforming growth
factor alpha in hepatocyte proliferation in regenerating nodules and i
n tumor cell proliferation in hepatocellular carcinoma tissues.